| Product Code: ETC6655953 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Enteric Disease Testing-Treatment Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Enteric Disease Testing-Treatment Market - Industry Life Cycle |
3.4 Canada Enteric Disease Testing-Treatment Market - Porter's Five Forces |
3.5 Canada Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Canada Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.7 Canada Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
3.8 Canada Enteric Disease Testing-Treatment Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Canada Enteric Disease Testing-Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of enteric diseases in Canada |
4.2.2 Growing awareness about the importance of early detection and treatment of enteric diseases |
4.2.3 Technological advancements in diagnostic testing and treatment options for enteric diseases |
4.3 Market Restraints |
4.3.1 High costs associated with enteric disease testing and treatment |
4.3.2 Limited access to healthcare facilities in certain regions of Canada |
4.3.3 Regulatory challenges in the approval of new diagnostic tests and treatments for enteric diseases |
5 Canada Enteric Disease Testing-Treatment Market Trends |
6 Canada Enteric Disease Testing-Treatment Market, By Types |
6.1 Canada Enteric Disease Testing-Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Bacterial Enteric Diseases, 2021- 2031F |
6.1.4 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Viral Enteric Diseases, 2021- 2031F |
6.1.5 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Parasitic Enteric Diseases, 2021- 2031F |
6.2 Canada Enteric Disease Testing-Treatment Market, By Therapeutics |
6.2.1 Overview and Analysis |
6.2.2 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Campylobacter, 2021- 2031F |
6.2.3 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Cryptosporidium, 2021- 2031F |
6.2.4 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By E-Coli, 2021- 2031F |
6.2.5 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Enteroviruses, 2021- 2031F |
6.2.6 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By RhinoViruses, 2021- 2031F |
6.2.7 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By RotaVirus, 2021- 2031F |
6.2.8 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Shigellosis, 2021- 2031F |
6.2.9 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Shigellosis, 2021- 2031F |
6.3 Canada Enteric Disease Testing-Treatment Market, By Testing Technology |
6.3.1 Overview and Analysis |
6.3.2 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.3.3 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.3.4 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.3.5 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Differential Light Scanning, 2021- 2031F |
6.3.6 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Information Technology, 2021- 2031F |
6.3.7 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By AI, 2021- 2031F |
6.3.8 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.9 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.10 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Enteric Disease Testing-Treatment Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.4 Canada Enteric Disease Testing-Treatment Market Revenues & Volume, By Physician Offices, 2021- 2031F |
7 Canada Enteric Disease Testing-Treatment Market Import-Export Trade Statistics |
7.1 Canada Enteric Disease Testing-Treatment Market Export to Major Countries |
7.2 Canada Enteric Disease Testing-Treatment Market Imports from Major Countries |
8 Canada Enteric Disease Testing-Treatment Market Key Performance Indicators |
8.1 Rate of adoption of new enteric disease testing technologies in Canada |
8.2 Number of healthcare facilities offering enteric disease testing and treatment services |
8.3 Patient satisfaction and outcomes following enteric disease testing and treatment |
9 Canada Enteric Disease Testing-Treatment Market - Opportunity Assessment |
9.1 Canada Enteric Disease Testing-Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Canada Enteric Disease Testing-Treatment Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.3 Canada Enteric Disease Testing-Treatment Market Opportunity Assessment, By Testing Technology, 2021 & 2031F |
9.4 Canada Enteric Disease Testing-Treatment Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Canada Enteric Disease Testing-Treatment Market - Competitive Landscape |
10.1 Canada Enteric Disease Testing-Treatment Market Revenue Share, By Companies, 2024 |
10.2 Canada Enteric Disease Testing-Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here